{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:14:02Z","timestamp":1783394042946,"version":"3.54.6"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08260-5","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:35:14Z","timestamp":1778578514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Copper transporters promote the malignant progression of glioblastoma by regulating the immunosuppressive tumour microenvironment via the SLC31A1-WNT5A axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Chunchun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6911-2471","authenticated-orcid":false,"given":"Yongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"8","key":"8260_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol"},{"issue":"5","key":"8260_CR2","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41588-025-02168-4","volume":"57","author":"A Spitzer","year":"2025","unstructured":"Spitzer A, Johnson KC, Nomura M, Garofano L, Nehar-Belaid D, Darnell NG, et al. Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics. Nat Genet. 2025;57(5):1168\u201378. https:\/\/doi.org\/10.1038\/s41588-025-02168-4.","journal-title":"Nat Genet"},{"key":"8260_CR3","doi-asserted-by":"publisher","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2016\u20142020. Neuro Oncol. 2023;25(Supplement_4):iv1\u201399. https:\/\/doi.org\/10.1093\/neuonc\/noad149.","DOI":"10.1093\/neuonc\/noad149"},{"issue":"12","key":"8260_CR4","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","volume":"185","author":"FS Varn","year":"2022","unstructured":"Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P, et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell. 2022;185(12):2184\u201399.e16. https:\/\/doi.org\/10.1016\/j.cell.2022.04.038.","journal-title":"Cell"},{"issue":"10","key":"8260_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331.","journal-title":"N Engl J Med"},{"issue":"10","key":"8260_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"key":"8260_CR7","doi-asserted-by":"publisher","first-page":"218185","DOI":"10.1016\/j.canlet.2025.218185","volume":"640","author":"T Jiang","year":"2026","unstructured":"Jiang T, Nam D-H, Ram Z, Poo W-S, Wang J, Boldbaatar D, et al. Updated clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2026;640:218185. https:\/\/doi.org\/10.1016\/j.canlet.2025.218185.","journal-title":"Cancer Lett"},{"issue":"3","key":"8260_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021;18(3):170\u201386. https:\/\/doi.org\/10.1038\/s41571-020-00447-z.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"8260_CR9","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41588-021-00926-8","volume":"53","author":"KC Johnson","year":"2021","unstructured":"Johnson KC, Anderson KJ, Courtois ET, Gujar AD, Barthel FP, Varn FS, et al. Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response. Nat Genet. 2021;53(10):1456\u201368. https:\/\/doi.org\/10.1038\/s41588-021-00926-8.","journal-title":"Nat Genet"},{"issue":"3","key":"8260_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2015.07.013","volume":"28","author":"J Kim","year":"2015","unstructured":"Kim J, Lee I-H, Cho HJ, Park C-K, Jung Y-S, Kim Y, et al. Spatiotemporal evolution of the primary glioblastoma Genome. Cancer Cell. 2015;28(3):318\u201328. https:\/\/doi.org\/10.1016\/j.ccell.2015.07.013.","journal-title":"Cancer Cell"},{"issue":"3","key":"8260_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1101\/gr.180612.114","volume":"25","author":"H Kim","year":"2015","unstructured":"Kim H, Zheng S, Amini SS, Virk SM, Mikkelsen T, Brat DJ, et al. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Genome Res Cold Spring Harbor Lab. 2015;25(3):316\u201327. https:\/\/doi.org\/10.1101\/gr.180612.114.","journal-title":"Genome Res Cold Spring Harbor Lab"},{"issue":"12","key":"8260_CR12","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang L, Jung J, Babikir H, Shamardani K, Jain S, Feng X, et al. A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat Cancer. 2022;3(12):1534\u201352. https:\/\/doi.org\/10.1038\/s43018-022-00475-x.","journal-title":"Nat Cancer"},{"issue":"4","key":"8260_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An integrative model of cellular States, plasticity, and genetics for glioblastoma. Cell. 2019;178(4):835\u201349.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.06.024.","journal-title":"Cell"},{"issue":"10","key":"8260_CR14","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","volume":"187","author":"AC Greenwald","year":"2024","unstructured":"Greenwald AC, Darnell NG, Hoefflin R, Simkin D, Mount CW, Gonzalez Castro LN, et al. Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell [Internet]. 2024;187(10):2485\u2013501.e26. https:\/\/doi.org\/10.1016\/j.cell.2024.03.029.","journal-title":"Cell"},{"issue":"3","key":"8260_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ccell.2023.12.015","volume":"42","author":"K-H Kim","year":"2024","unstructured":"Kim K-H, Migliozzi S, Koo H, Hong J-H, Park SM, Kim S, et al. Integrated proteogenomic characterization of glioblastoma evolution. Cancer Cell. 2024;42(3):358\u201377.e8. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.015.","journal-title":"Cancer Cell"},{"key":"8260_CR16","doi-asserted-by":"publisher","unstructured":"Jackson C, Cherry C, Bom S, Dykema AG, Wang R, Thompson E, et al. Distinct myeloid-derived suppressor cell populations in human glioblastoma. Science. New York, N.Y. 2025;387(6731):eabm5214. https:\/\/doi.org\/10.1126\/science.abm5214.","DOI":"10.1126\/science.abm5214"},{"key":"8260_CR17","doi-asserted-by":"publisher","unstructured":"Pan C, Ji Z, Wang Q, Zhang Z, Wang Z, Li C, et al. Cuproptosis: mechanisms, biological significance, and advances in disease treatment\u2014A systematic review. CNS Neurosci Ther. 2024;30(9):e70039. https:\/\/doi.org\/10.1111\/cns.70039.","DOI":"10.1111\/cns.70039"},{"issue":"1","key":"8260_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Sig Transduct Target Ther. 2022;7(1):378. https:\/\/doi.org\/10.1038\/s41392-022-01229-y.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"8260_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.13276","volume":"321","author":"W-Q Liu","year":"2024","unstructured":"Liu W-Q, Lin W-R, Yan L, Xu W-H, Yang J. Copper homeostasis and cuproptosis in cancer immunity and therapy. Immunol Rev. 2024;321(1):211\u201327. https:\/\/doi.org\/10.1111\/imr.13276.","journal-title":"Immunological Rev"},{"key":"8260_CR20","doi-asserted-by":"publisher","first-page":"102214","DOI":"10.1016\/j.arr.2024.102214","volume":"95","author":"M Huang","year":"2024","unstructured":"Huang M, Zhang Y, Liu X. The mechanism of cuproptosis in Parkinson\u2019s disease. Ageing Res Rev. 2024;95:102214. https:\/\/doi.org\/10.1016\/j.arr.2024.102214.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"8260_CR21","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/jn\/109.11.1979","volume":"109","author":"KE Mason","year":"1979","unstructured":"Mason KE. A conspectus of research on copper metabolism and requirements of man. J Nutr. 1979;109(11):1979\u20132066. https:\/\/doi.org\/10.1093\/jn\/109.11.1979.","journal-title":"J Nutr"},{"issue":"6","key":"8260_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3945\/an.111.001222","volume":"2","author":"JF Collins","year":"2011","unstructured":"Collins JF, Klevay LM. Copper. Adv Nutr. Bethesda, Md. 2011;2(6):520\u201322. https:\/\/doi.org\/10.3945\/an.111.001222.","journal-title":"Adv Nutr"},{"issue":"11","key":"8260_CR23","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.4103\/1673-5374.393107","volume":"19","author":"S Roy","year":"2024","unstructured":"Roy S, Lutsenko S. Mechanism of Cu entry into the brain: many unanswered questions. Neural Regener Res. 2024;19(11):2421. https:\/\/doi.org\/10.4103\/1673-5374.393107.","journal-title":"Neural Regener Res"},{"issue":"7960","key":"8260_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41586-023-06017-4","volume":"617","author":"S Solier","year":"2023","unstructured":"Solier S, M\u00fcller S, Ca\u00f1eque T, Versini A, Mansart A, Sindikubwabo F, et al. A druggable copper-signalling pathway that drives inflammation. Nature. 2023;617(7960):386\u201394. https:\/\/doi.org\/10.1038\/s41586-023-06017-4.","journal-title":"Nature"},{"issue":"1","key":"8260_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22(1):46. https:\/\/doi.org\/10.1186\/s12943-023-01732-y.","journal-title":"Mol Cancer"},{"issue":"20","key":"8260_CR26","doi-asserted-by":"publisher","first-page":"19581","DOI":"10.1021\/acsnano.3c07775","volume":"17","author":"W Wang","year":"2023","unstructured":"Wang W, Mo W, Hang Z, Huang Y, Yi H, Sun Z, et al. Cuproptosis: harnessing transition metal for cancer therapy. ACS Nano. Am Chem Soc. 2023;17(20):19581\u201399. https:\/\/doi.org\/10.1021\/acsnano.3c07775.","journal-title":"ACS Nano. Am Chem Soc"},{"issue":"1","key":"8260_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-024-01589-8","volume":"17","author":"C Zhang","year":"2024","unstructured":"Zhang C, Huang T, Li L. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17(1):68. https:\/\/doi.org\/10.1186\/s13045-024-01589-8.","journal-title":"J Hematol Oncol"},{"key":"8260_CR28","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y, et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updates. 2024;72:101018. https:\/\/doi.org\/10.1016\/j.drup.2023.101018.","journal-title":"Drug Resist Updates"},{"issue":"1","key":"8260_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s11658-024-00608-3","volume":"29","author":"L Li","year":"2024","unstructured":"Li L, Zhou H, Zhang C. Cuproptosis in cancer: biological implications and therapeutic opportunities. Cell Mol Biol Lett. 2024;29(1):91. https:\/\/doi.org\/10.1186\/s11658-024-00608-3.","journal-title":"Cell Mol Biol Lett"},{"key":"8260_CR30","doi-asserted-by":"publisher","first-page":"116874","DOI":"10.1016\/j.biopha.2024.116874","volume":"176","author":"X-Y Huang","year":"2024","unstructured":"Huang X-Y, Shen J-Y, Huang K, Wang L, Sethi G, Ma Z. Cuproptosis in cancers: function and implications from bench to bedside. Biomed Pharmacother. 2024;176:116874. https:\/\/doi.org\/10.1016\/j.biopha.2024.116874.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"8260_CR31","doi-asserted-by":"publisher","first-page":"189013","DOI":"10.1016\/j.bbcan.2023.189013","volume":"1878","author":"X Liu","year":"2023","unstructured":"Liu X, Luo B, Wu X, Tang Z. Cuproptosis and cuproptosis-related genes: emerging potential therapeutic targets in breast cancer. Biochim Biophys Acta Rev Cancer. 2023;1878(6):189013. https:\/\/doi.org\/10.1016\/j.bbcan.2023.189013.","journal-title":"Biochim Et Biophys Acta (BBA) - Rev Cancer"},{"issue":"1","key":"8260_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-023-01752-8","volume":"22","author":"Y Qin","year":"2023","unstructured":"Qin Y, Liu Y, Xiang X, Long X, Chen Z, Huang X, et al. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Mol Cancer. 2023;22(1):59. https:\/\/doi.org\/10.1186\/s12943-023-01752-8.","journal-title":"Mol Cancer"},{"issue":"3","key":"8260_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","volume":"164","author":"M Ceccarelli","year":"2016","unstructured":"Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell. 2016;164(3):550\u201363. https:\/\/doi.org\/10.1016\/j.cell.2015.12.028.","journal-title":"Cell"},{"issue":"1","key":"8260_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang K-N, Wang Q, Li G, Zeng F, Zhang Y, et al. Chinese glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients. Genomics Proteomics Bioinf. 2021;19(1):1\u201312. https:\/\/doi.org\/10.1016\/j.gpb.2020.10.005.","journal-title":"Genomics, Proteomics Bioinf"},{"issue":"6389","key":"8260_CR35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1126\/science.aaf2666","volume":"360","author":"RB Puchalski","year":"2018","unstructured":"Puchalski RB, Shah N, Miller J, Dalley R, Nomura SR, Yoon J-G, et al. An anatomic transcriptional atlas of human glioblastoma. Science. New York, N.Y. 2018;360(6389):660\u201363. https:\/\/doi.org\/10.1126\/science.aaf2666.","journal-title":"Science"},{"issue":"1","key":"8260_CR36","doi-asserted-by":"publisher","first-page":"10885","DOI":"10.1038\/s41467-024-55243-5","volume":"15","author":"F Wang","year":"2024","unstructured":"Wang F, Dong J, Xu Y, Jin J, Xu Y, Yan X, et al. Turning attention to tumor\u2013host interface and focus on the peritumoral heterogeneity of glioblastoma. Nat Commun. 2024;15(1):10885. https:\/\/doi.org\/10.1038\/s41467-024-55243-5.","journal-title":"Nat Commun"},{"issue":"1","key":"8260_CR37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41467-023-36707-6","volume":"14","author":"Y Ren","year":"2023","unstructured":"Ren Y, Huang Z, Zhou L, Xiao P, Song J, He P, et al. Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. Nat Commun. 2023;14(1):1028. https:\/\/doi.org\/10.1038\/s41467-023-36707-6.","journal-title":"Nat Commun"},{"issue":"34","key":"8260_CR38","doi-asserted-by":"publisher","first-page":"12550","DOI":"10.1073\/pnas.1405839111","volume":"111","author":"BJ Gill","year":"2014","unstructured":"Gill BJ, Pisapia DJ, Malone HR, Goldstein H, Lei L, Sonabend A, et al. MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma. Proc Natl Acad Sci USA. 2014;111(34):12550\u201355. https:\/\/doi.org\/10.1073\/pnas.1405839111.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"8260_CR39","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573\u201387.e29. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048.","journal-title":"Cell"},{"issue":"1","key":"8260_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13046-025-03454-z","volume":"44","author":"J Huang","year":"2025","unstructured":"Huang J, Zhu Y, Zeng W, Zhang Y, Xia W, Xia F, et al. Single-cell transcriptome analysis reveals the malignant characteristics of tumour cells and the immunosuppressive landscape in HER2-positive inflammatory breast cancer. J Exp Clin Cancer Res. 2025;44(1):196. https:\/\/doi.org\/10.1186\/s13046-025-03454-z.","journal-title":"J Exp Clin Cancer Res"},{"key":"8260_CR41","doi-asserted-by":"publisher","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","DOI":"10.1093\/nar\/gkv007"},{"issue":"5","key":"8260_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Intgr Biol. 2012;16(5):284\u201387. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"Omics: J Intgr Biol"},{"issue":"6","key":"8260_CR43","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39(6):845\u201365.e7. https:\/\/doi.org\/10.1016\/j.ccell.2021.04.014.","journal-title":"Cancer Cell"},{"key":"8260_CR44","doi-asserted-by":"publisher","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900\u20138. https:\/\/doi.org\/10.1093\/nar\/gky939.","DOI":"10.1093\/nar\/gky939"},{"issue":"1","key":"8260_CR45","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"issue":"1","key":"8260_CR46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6.","journal-title":"Nat Commun"},{"key":"8260_CR47","doi-asserted-by":"publisher","unstructured":"Wu C, Tan J, Wang X, Qin C, Long W, Pan Y, et al. Pan-cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators. Imeta. 2023;2(1):e68. https:\/\/doi.org\/10.1002\/imt2.68.","DOI":"10.1002\/imt2.68"},{"issue":"12","key":"8260_CR48","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1158\/2159-8290.CD-22-0196","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, et al. Natural coevolution of tumor and immunoenvironment in glioblastoma. Cancer Discov. 2022;12(12):2820\u201337. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0196.","journal-title":"Cancer Discov"},{"issue":"5","key":"8260_CR49","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang Z, Su W, Wei X, Pan Y, Xing M, Niu L, et al. Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis. Cancer Cell. 2025;43(5):937\u201354.e9. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.015.","journal-title":"Cancer Cell"},{"issue":"8","key":"8260_CR50","doi-asserted-by":"publisher","first-page":"112945","DOI":"10.1016\/j.celrep.2023.112945","volume":"42","author":"Z Yang","year":"2023","unstructured":"Yang Z, Su W, Wei X, Qu S, Zhao D, Zhou J, et al. HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. 2023;42(8):112945. https:\/\/doi.org\/10.1016\/j.celrep.2023.112945.","journal-title":"Cell Rep"},{"issue":"2","key":"8260_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1039\/c8mt00280k","volume":"11","author":"Z Wu","year":"2019","unstructured":"Wu Z, Zhang W, Kang YJ. Copper affects the binding of HIF-1\u03b1 to the critical motifs of its target genes. Metallomics. 2019;11(2):429\u201338. https:\/\/doi.org\/10.1039\/c8mt00280k.","journal-title":"Metallomics"},{"key":"8260_CR52","doi-asserted-by":"publisher","unstructured":"Salvo J, Sandoval C. Role of copper nanoparticles in wound healing for chronic wounds: literature review. Burns Trauma. 2022;10:tkab047. https:\/\/doi.org\/10.1093\/burnst\/tkab047.","DOI":"10.1093\/burnst\/tkab047"},{"issue":"5","key":"8260_CR53","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","volume":"42","author":"W Wang","year":"2024","unstructured":"Wang W, Li T, Cheng Y, Li F, Qi S, Mao M, et al. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell. 2024;42(5):815\u201332.e12. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.013.","journal-title":"Cancer Cell"},{"issue":"1","key":"8260_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12964-024-01726-3","volume":"22","author":"TTT Vo","year":"2024","unstructured":"Vo TTT, Peng T-Y, Nguyen TH, Bui TNH, Wang C-S, Lee W-J, et al. The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm. Cell Commun Signal. 2024;22(1):353. https:\/\/doi.org\/10.1186\/s12964-024-01726-3.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"8260_CR55","doi-asserted-by":"publisher","first-page":"101314","DOI":"10.1016\/j.jbc.2021.101314","volume":"297","author":"M Grasso","year":"2021","unstructured":"Grasso M, Bond GJ, Kim Y-J, Boyd S, Matson Dzebo M, Valenzuela S, et al. The copper chaperone CCS facilitates copper binding to MEK1\/2 to promote kinase activation. J Biol Chem. 2021;297(6):101314. https:\/\/doi.org\/10.1016\/j.jbc.2021.101314.","journal-title":"J Biol Chem"},{"issue":"10","key":"8260_CR56","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc4000","volume":"15","author":"CJ Caunt","year":"2015","unstructured":"Caunt CJ, Sale MJ, Smith PD, Cook SJ. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road. Nat Rev Cancer. 2015;15(10):577\u201392. https:\/\/doi.org\/10.1038\/nrc4000.","journal-title":"Nat Rev Cancer"},{"key":"8260_CR57","doi-asserted-by":"publisher","unstructured":"Guo J, Cheng J, Zheng N, Zhang X, Dai X, Zhang L, et al. Copper promotes tumorigenesis by activating the PDK1-AKT oncogenic pathway in a copper transporter 1 dependent manner. Adv Sci (Weinh). Weinheim, Baden-Wurttemberg, Germany. 2021;8(18):e2004303. https:\/\/doi.org\/10.1002\/advs.202004303.","DOI":"10.1002\/advs.202004303"},{"issue":"8","key":"8260_CR58","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41416-022-02127-4","volume":"128","author":"X Zhang","year":"2023","unstructured":"Zhang X, Jiang Q, Su Y, Bu L, Sun Z, Wu X, et al. AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy. Br J Cancer. 2023;128(8):1452\u201365. https:\/\/doi.org\/10.1038\/s41416-022-02127-4.","journal-title":"Br J Cancer"},{"issue":"1","key":"8260_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40364-024-00677-8","volume":"12","author":"S Zhang","year":"2024","unstructured":"Zhang S, Huang Q, Ji T, Li Q, Hu C. Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy. Biomark Res. 2024;12(1):130. https:\/\/doi.org\/10.1186\/s40364-024-00677-8.","journal-title":"Biomark Res"},{"key":"8260_CR60","doi-asserted-by":"publisher","unstructured":"Lu X, Chen X, Lin C, Yi Y, Zhao S, Zhu B, et al. Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy. Adv Sci (Weinh). Weinheim, Baden-Wurttemberg, Germany. 2024;11(18):e2309984. https:\/\/doi.org\/10.1002\/advs.202309984.","DOI":"10.1002\/advs.202309984"},{"issue":"1","key":"8260_CR61","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","volume":"10","author":"Z Guo","year":"2025","unstructured":"Guo Z, Chen D, Yao L, Sun Y, Li D, Le J, et al. The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Sig Transduct Target Ther. 2025;10(1):149. https:\/\/doi.org\/10.1038\/s41392-025-02192-0.","journal-title":"Sig Transduct Target Ther"},{"key":"8260_CR62","doi-asserted-by":"publisher","first-page":"122223","DOI":"10.1016\/j.lfs.2023.122223","volume":"334","author":"Z Tian","year":"2023","unstructured":"Tian Z, Jiang S, Zhou J, Zhang W. Copper homeostasis and cuproptosis in mitochondria. Life Sci. 2023;334:122223. https:\/\/doi.org\/10.1016\/j.lfs.2023.122223.","journal-title":"Life Sci"},{"key":"8260_CR63","doi-asserted-by":"publisher","unstructured":"Anjana V, Anand S, Thakur P, Pal R, Acharjee S, Singh R, et al. Copper homeostasis at the Crossroads of cellular metabolism, epigenetic regulation and protein trafficking. Traffic. Copenhagen, Denmark. 2025;26(10\u201312):e70024. https:\/\/doi.org\/10.1111\/tra.70024.","DOI":"10.1111\/tra.70024"},{"key":"8260_CR64","doi-asserted-by":"publisher","first-page":"216157","DOI":"10.1016\/j.canlet.2023.216157","volume":"561","author":"X Wang","year":"2023","unstructured":"Wang X, Zhou M, Liu Y, Si Z. Cope with copper: from copper linked mechanisms to copper-based clinical cancer therapies. Cancer Lett. 2023;561:216157. https:\/\/doi.org\/10.1016\/j.canlet.2023.216157.","journal-title":"Cancer Lett"},{"issue":"5","key":"8260_CR65","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21(5):370\u201388. https:\/\/doi.org\/10.1038\/s41571-024-00876-0.","journal-title":"Nat Rev Clin Oncol"},{"key":"8260_CR66","doi-asserted-by":"publisher","first-page":"113599","DOI":"10.1016\/j.biopha.2022.113599","volume":"155","author":"MLP Bueno","year":"2022","unstructured":"Bueno MLP, Saad STO, Roversi FM. WNT5A in tumor development and progression: a comprehensive review. Biomed Pharmacother. 2022;155:113599. https:\/\/doi.org\/10.1016\/j.biopha.2022.113599.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8260_CR67","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1038\/s41467-025-58748-9","volume":"16","author":"A Harada","year":"2025","unstructured":"Harada A, Yasumizu Y, Harada T, Fumoto K, Sato A, Maehara N, et al. Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression. Nat Commun. 2025;16(1):3653. https:\/\/doi.org\/10.1038\/s41467-025-58748-9.","journal-title":"Nat Commun"},{"issue":"5","key":"8260_CR68","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2016.10.039","volume":"167","author":"B Hu","year":"2016","unstructured":"Hu B, Wang Q, Wang YA, Hua S, Sauv\u00e9 C-EG, Ong D, et al. Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell. 2016;167(5):1281\u201395.e18. https:\/\/doi.org\/10.1016\/j.cell.2016.10.039.","journal-title":"Cell"},{"issue":"1","key":"8260_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13046-022-02333-1","volume":"41","author":"N Trivieri","year":"2022","unstructured":"Trivieri N, Visioli A, Mencarelli G, Cariglia MG, Marongiu L, Pracella R, et al. Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh\/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy. J Exp Clin Cancer Res. 2022;41(1):139. https:\/\/doi.org\/10.1186\/s13046-022-02333-1.","journal-title":"J Exp Clin Cancer Res"},{"issue":"32","key":"8260_CR70","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1038\/s41388-021-01922-2","volume":"40","author":"T Chen","year":"2021","unstructured":"Chen T, Zhang F, Liu J, Huang Z, Zheng Y, Deng S, et al. Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells. Oncogene. 2021;40(32):5081\u201394. https:\/\/doi.org\/10.1038\/s41388-021-01922-2.","journal-title":"Oncogene"},{"issue":"6","key":"8260_CR71","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41422-020-00451-z","volume":"31","author":"X Wang","year":"2021","unstructured":"Wang X, Zhou R, Xiong Y, Zhou L, Yan X, Wang M, et al. Sequential fate-switches in stem-like cells drive the tumorigenic trajectory from human neural stem cells to malignant glioma. Cell Res. 2021;31(6):684\u2013702. https:\/\/doi.org\/10.1038\/s41422-020-00451-z.","journal-title":"Cell Res"},{"issue":"7","key":"8260_CR72","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1158\/2159-8290.CD-20-0057","volume":"10","author":"AR Pine","year":"2020","unstructured":"Pine AR, Cirigliano SM, Nicholson JG, Hu Y, Linkous A, Miyaguchi K, et al. Tumor microenvironment is critical for the maintenance of cellular States found in primary glioblastomas. Cancer Discov. 2020;10(7):964\u201379. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0057.","journal-title":"Cancer Discov"},{"key":"8260_CR73","doi-asserted-by":"publisher","unstructured":"Chen X, Pang B, Liu Y, Wang J, Zheng L, Chang Y, et al. Targeting WTAP\/ROR1\/WNT5A-Mediated crosstalk between glioma stem cells and macrophages to normalize tumor vasculature and enhance chemotherapy. Adv Sci (Weinh). Weinheim, Baden-Wurttemberg, Germany. 2026;13(21):e20661. https:\/\/doi.org\/10.1002\/advs.202520661.","DOI":"10.1002\/advs.202520661"},{"issue":"7","key":"8260_CR74","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41375-025-02616-4","volume":"39","author":"MK Hasan","year":"2025","unstructured":"Hasan MK, Widhopf Ii GF, Ghia EM, Kipps TJ. Wnt5a induces ROR1 dependent NF-\u03baB activation to enhance MMP-9 expression and invasiveness in chronic lymphocytic leukemia. Leukemia. 2025;39(7):1661\u201369. https:\/\/doi.org\/10.1038\/s41375-025-02616-4.","journal-title":"Leukemia"},{"key":"8260_CR75","doi-asserted-by":"publisher","first-page":"101125","DOI":"10.1016\/j.neo.2025.101125","volume":"61","author":"X Li","year":"2025","unstructured":"Li X, Ge J, Wan M, Feng T, Li X, Zhang H, et al. SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer. Neoplasia. New York, N.Y. 2025;61:101125. https:\/\/doi.org\/10.1016\/j.neo.2025.101125.","journal-title":"Neoplasia"},{"issue":"1","key":"8260_CR76","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/s41467-024-54469-7","volume":"15","author":"M Guan","year":"2024","unstructured":"Guan M, Cheng K, Xie X-T, Li Y, Ma M-W, Zhang B, et al. Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy. Nat Commun. 2024;15(1):10060. https:\/\/doi.org\/10.1038\/s41467-024-54469-7.","journal-title":"Nat Commun"},{"key":"8260_CR77","doi-asserted-by":"publisher","unstructured":"Chang J, Yin W, Zhi H, Chen S, Sun J, Zhao Y, et al. Copper deposition in Polydopamine Nanostructure to promote cuproptosis by catalytically inhibiting copper exporters of tumor cells for cancer immunotherapy. Small. Weinheim an der Bergstrasse, Germany. 2024;20(27):e2308565. https:\/\/doi.org\/10.1002\/smll.202308565.","DOI":"10.1002\/smll.202308565"},{"issue":"4","key":"8260_CR78","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ccell.2025.03.012","volume":"43","author":"J Luo","year":"2025","unstructured":"Luo J, Solit DB. Leveraging real-world data to advance biomarker discovery and precision oncology. Cancer Cell. 2025;43(4):606\u201310. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.012.","journal-title":"Cancer Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08260-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08260-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08260-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:24:37Z","timestamp":1783391077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08260-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8260"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08260-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this study, the collection of clinical sample data was carried out strictly in accordance with the regulations of the Ethics Committee of Xiangya Hospital of Central South University. All participants involved in this study have signed written informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"860"}}